Granules India shares surged more than 2% after the US FDA granted its Andhra Pradesh Unit V facility a ‘No Action Indicated’ (NAI) status.
This designation follows a recent inspection, confirming that the facility meets the stringent current Good Manufacturing Practices (cGMP) standards, with no further regulatory actions required.
The stock opened at ₹572.15, reached a high of ₹590.50, and hit a low of ₹563.00, reflecting investor confidence in the company’s commitment to quality in pharmaceuticals.
As of 11:25 am, Granules India shares were trading 1.06% higher at Rs 578.15 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
